Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1939 1
1942 3
1946 4
1947 7
1948 8
1949 4
1950 4
1951 7
1952 3
1953 7
1954 7
1955 3
1956 5
1957 4
1958 7
1959 5
1960 12
1961 6
1962 2
1963 3
1964 5
1965 6
1966 6
1967 9
1968 5
1969 11
1970 11
1971 11
1972 10
1973 5
1974 13
1975 14
1976 8
1977 11
1978 6
1979 12
1980 17
1981 11
1982 7
1983 15
1984 6
1985 12
1986 13
1987 16
1988 14
1989 19
1990 18
1991 23
1992 16
1993 17
1994 18
1995 16
1996 5
1997 12
1998 9
1999 14
2000 15
2001 18
2002 13
2003 27
2004 19
2005 17
2006 25
2007 20
2008 28
2009 17
2010 19
2011 24
2012 19
2013 24
2014 33
2015 20
2016 35
2017 39
2018 39
2019 52
2020 40
2021 40
2022 38
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

1,066 results
Results by year
Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. Among authors: weaver r. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Time-dependent CYP inhibition.
Riley RJ, Grime K, Weaver R. Riley RJ, et al. Among authors: weaver r. Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):51-66. doi: 10.1517/17425255.3.1.51. Expert Opin Drug Metab Toxicol. 2007. PMID: 17269894 Review.
Authors' Reply.
Weaver RG, Tonelli M, Lamb EJ, Hemmelgarn BR. Weaver RG, et al. J Am Soc Nephrol. 2020 Aug;31(8):1916-1917. doi: 10.1681/ASN.2020050707. Epub 2020 Jul 8. J Am Soc Nephrol. 2020. PMID: 32737208 Free PMC article. No abstract available.
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.
Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-Sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Weaver RJ, et al. Nat Rev Drug Discov. 2020 Feb;19(2):131-148. doi: 10.1038/s41573-019-0048-x. Epub 2019 Nov 20. Nat Rev Drug Discov. 2020. PMID: 31748707 Free article. Review.
Opportunities for Healthy Learning as a Social Determinant of Health.
Moore JB, Hill SR Jr, Weaver RG. Moore JB, et al. Among authors: weaver rg. J Public Health Manag Pract. 2019 Nov/Dec;25(6):523-524. doi: 10.1097/PHH.0000000000001089. J Public Health Manag Pract. 2019. PMID: 31569188 No abstract available.
1,066 results